Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on ...
Shares of Danish rival Novo Nordisk slipped after it sought to snatch Pfizer target Metsera from the American drug giant's arms. Novo launched an unsolicited bid valued at up to $9 billion for obesity ...
3hon MSN
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
Through an exclusive partnership with Eli Lilly, the company has begun distributing and promoting Yurpeak (Tirzepatide) in ...
A $2.5 million grant from Lilly Endowment to the Indiana State Museum and Historic Sites will fund "a multi-year ...
Eli Lilly shares rise as Q3 revenue jumps 54% to $17.6 billion, earnings top estimates, and analysts lift price targets on ...
The drug, which Lilly in-licensed four years ago and is designed to inhibit a protein known as P2X7, did not meet the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback